allcancercure.com

UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers. The Institute of Urologic Oncology at UCLA challenges the traditional model of academic departments operating independently of each other, bringing a multi-disciplinary team of scientists and physicians together as part of one cohesive [...]

Making Prostate Cancer Matter – Survey Reveals That Majority Of People Unaware That Men Diagnosed With The Most Common Cancer Subject To Injustice People across the UK are still unaware that men living with prostate cancer – the most common cancer in men – continue to have to deal with the ‘historical legacy of neglect’ [...]

A novel compound in development by AstraZeneca as an oral tablet for hormone resistant prostate cancer (HRPC), ZD4054, could improve overall survival (OS) in men with metastatic HRPC, according to Phase II data published today in European Urology.[1] Men with advanced prostate cancer may receive initially effective treatment with hormonal therapies to which the majority [...]

The Prostate Cancer Foundation (PCF) has made presentations from its 2008 Scientific Retreat available online. The PCF’s annual retreat provides a forum to review advances in prostate cancer research aimed at reducing death and suffering from this prevalent men’s disease. The three-day event was held in October at Incline Village, Nevada, and was attended by [...]

Noroviruses are a group of viruses that are the most common cause of acute gastroenteritis and the HPA estimates that they affect between 600,000 and a million people in the UK each year. Infection can spread rapidly, and as Norovirus outbreaks continue to hit the headlines, the RIPH is pleased to announce it is running [...]

One in four Americans in the hospital right now has a urinary catheter. One percent of them will get a urinary tract infection from that catheter. All of those will require antibiotics. A few may suffer life-threatening complications. And with every new case, UTIs will retain their title of “most common hospital-acquired infection,” responsible for [...]

Tengion, Inc., a clinical stage regenerative medicine company focused on the development of neo-organs and neo-vessels, announced it is initiating its third Phase 2 multi-center clinical trial of its Neo-Bladder Augment derived from a patient’s own (autologous) cells. The U.S.-based study is being conducted at five hospitals in 10 adult patients with non-neurogenic over-active bladder [...]

A study published this week in the open access journal PLoS Medicine presents convincing evidence that intracellular bacterial communities (IBCs) commonly exist in women with bladder infections and may contribute to the recurrence of these infections. In mice it has already been established that Escherichia coli (E coli), a type of bacterium that causes urinary [...]

UroToday.com- The creation of a neophallus has been a difficult reconstructive challenge and the search for the perfect donor site and surgical procedure continues. Recently, Sava Perovic and colleagues from Belgrade Serbia, describe their experience with total phalloplasty using a musculocutaneous latissimus dorsi flap (MLD). The manuscript is published in the October 2007 issue of [...]

UroToday.com- Proper assessment of post traumatic posterior urethral distraction defects is crucial for the selection of the correct surgical procedure and to aid in the ease of operative repair. Factors which affect the complexity of the procedure are length of urethral defect, degree of prostatic displacement, extent of scar tissue, and the presence of paraurethral [...]